Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer.
Grandis JR, Skorupski KA, Cheng N, Cui Z, Li H, Woerner LC, Gencel-Augusto J, Zeng Y, Shiah JV, Bhola NE, Sen M, Blum K, Kim MO, York D, Rebhun RB, Chang H, Murad NF, Olshen AB, Sparger EE, Johnson DE.
Grandis JR, et al. Among authors: sparger ee.
Cancer Cell. 2025 Nov 10;43(11):2051-2068.e9. doi: 10.1016/j.ccell.2025.07.015. Epub 2025 Aug 28.
Cancer Cell. 2025.
PMID: 40882634
Free article.
Clinical Trial.